0,914  0,003  Lipoprotein disorders treatment
0,900  0,005  Cyclophilin D inhibitor
0,900  0,005  Antidiabetic
0,892  0,004  Atherosclerosis treatment
0,862  0,001  Aconitate hydratase inhibitor
0,854  0,003  Hypolipemic
0,845  0,004  GST A substrate
0,778  0,001  Fumarate hydratase inhibitor
0,765  0,001  Glutamate dehydrogenase inhibitor
0,757  0,004  Renal disease treatment
0,725  0,005  Antipsoriatic
0,719  0,005  Urologic disorders treatment
0,714  0,004  Wound healing agent
0,711  0,001  Triose-phosphate isomerase inhibitor
0,703  0,002  GABA C receptor agonist
0,705  0,005  Hepatic disorders treatment
0,705  0,014  Embryotoxic
0,693  0,012  Carcinogenic
0,671  0,003  Alpha-N-acetylglucosaminidase inhibitor
0,657  0,002  Phenylalanine 4-hydroxylase inhibitor
0,658  0,004  Renal failure treatment
0,679  0,035  Antiinflammatory
0,649  0,013  Antihypercholesterolemic
0,628  0,001  Carbamoyl phosphate synthetase inhibitor
0,628  0,004  Antiulcerative
0,632  0,015  Antineoplastic (solid tumors)
0,622  0,009  Inflammatory Bowel disease treatment
0,610  0,001  Phosphofructokinase-1 inhibitor
0,609  0,009  Antidiabetic (type 2)
0,608  0,018  Cholesterol antagonist
0,594  0,020  Aldehyde oxidase inhibitor
0,579  0,010  Antifungal
0,573  0,013  Antioxidant
0,576  0,016  Immunosuppressant
0,559  0,004  Chelator
0,557  0,004  GST P1-1 substrate
0,562  0,009  Platelet antagonist
0,547  0,003  Peroxisome proliferator-activated receptor gamma agonist
0,557  0,014  NOS3 expression inhibitor
0,572  0,030  TNF expression inhibitor
0,540  0,013  FMO1 substrate
0,546  0,020  Antipruritic, allergic
0,551  0,028  Teratogen
0,531  0,009  Antihypertriglyceridemic
0,545  0,023  Antithrombotic
0,538  0,018  Mutagenic
0,524  0,005  Amylase inhibitor
0,536  0,019  Histamine release inhibitor
0,519  0,004  Tyrosine 3 hydroxylase inhibitor
0,527  0,014  Metabolic disease treatment
0,521  0,020  CTGF expression inhibitor
0,511  0,010  Antidiabetic symptomatic
0,507  0,013  Chronic obstructive pulmonary disease treatment
0,502  0,008  Anesthetic general
0,497  0,003  Porphobilinogen synthase inhibitor
0,508  0,014  Hypoglycemic
0,493  0,004  Alcohol oxidase inhibitor
0,501  0,013  DNA synthesis inhibitor
0,532  0,049  Caspase 9 stimulant
0,481  0,003  Ferrochelatase inhibitor
0,477  0,008  Hepatoprotectant
0,471  0,005  GST M1-1 substrate
0,502  0,037  Antiobesity
0,479  0,015  Eye irritation, high
0,474  0,012  Peroxidase inhibitor
0,465  0,003  Succinate dehydrogenase inhibitor
0,487  0,026  Ulceration
0,480  0,022  UGT1A9 substrate
0,462  0,005  Insulin secretagoues
0,490  0,033  Antineoplastic (myeloid leukemia)
0,469  0,016  UGT2B4 substrate
0,461  0,014  UDP-glucuronosyltransferase substrate
0,477  0,033  GABA C receptor rho-3 antagonist
0,441  0,008  5 Hydroxytryptamine uptake stimulant
0,435  0,003  Excitatory amino acid transporter EAAC1 inhibitor
0,478  0,047  Antibacterial
0,471  0,043  5 Hydroxytryptamine release inhibitor
0,432  0,011  Abortion inducer
0,438  0,018  Radiosensitizer
0,439  0,025  Cardiovascular analeptic
0,424  0,013  FMO3 substrate
0,410  0,016  Skin irritative effect
0,408  0,016  Anticoagulant
0,397  0,004  Aminoacyl-tRNA synthetase inhibitor
0,403  0,014  Antiparkinsonian, rigidity relieving
0,400  0,017  Sodium/bile acid cotransporter inhibitor
0,383  0,003  Argininosuccinate synthase inhibitor
0,411  0,037  AR expression inhibitor
0,429  0,055  CYP3A4 substrate
0,417  0,050  Vasodilator, peripheral
0,387  0,021  Interleukin agonist
0,396  0,039  Analeptic
0,388  0,031  Interleukin 2 agonist
0,404  0,048  Bone diseases treatment
0,369  0,013  Antipruritic, non-allergic
0,357  0,003  Peroxisome proliferator-activated receptor delta antagonist
0,353  0,001  Antineoplastic alkaloid
0,370  0,024  Flavin-containing monooxygenase substrate
0,372  0,027  Pyruvate kinase inhibitor
0,360  0,016  UGT2B7 substrate
0,359  0,019  Antimutagenic
0,356  0,022  Growth hormone agonist
0,373  0,039  Chemoprotective
0,342  0,009  Glutathione S-transferase substrate
0,362  0,029  Angiogenesis stimulant
0,334  0,005  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,342  0,013  Gastrin inhibitor
0,334  0,005  Antispirochetal
0,338  0,016  UGT1A3 substrate
0,358  0,037  Antihypoxic
0,328  0,008  Carcinogenic, group 1
0,352  0,033  UGT1A6 substrate
0,324  0,006  Adenylate kinase inhibitor
0,325  0,010  Phospholipase A2 inhibitor
0,331  0,018  VCAM1 expression inhibitor
0,356  0,046  Calcium channel activator
0,316  0,007  Antianemic
0,314  0,009  UGT2B9 substrate
0,323  0,017  Lipocortins synthesis antagonist
0,315  0,010  Antihyperlipoproteinemic
0,355  0,054  Respiratory analeptic
0,309  0,010  Cholesterol synthesis inhibitor
0,342  0,043  Cytostatic
0,337  0,041  Cardiodepressant
0,370  0,073  CYP2C9 substrate
0,334  0,040  Superoxide dismutase inhibitor
0,295  0,004  Glutamate decarboxylase inhibitor
0,318  0,027  UGT1A4 substrate
0,305  0,015  Antineoplastic antimetabolite
0,332  0,044  Proliferative diseases treatment
0,282  0,001  Glucose-6-phosphate isomerase inhibitor
0,332  0,055  Antiosteoporotic
0,283  0,007  Catenin beta inhibitor
0,280  0,009  UGT2B1 substrate
0,321  0,050  NOS2 expression inhibitor
0,290  0,019  Monophenol monooxygenase inhibitor
0,316  0,049  Insulysin inhibitor
0,286  0,020  Antiparkinsonian, tremor relieving
0,268  0,004  Biliverdin reductase inhibitor
0,265  0,002  ATP citrate lysase inhibitor
0,304  0,042  Antiparasitic
0,295  0,033  UGT1A1 substrate
0,283  0,022  Interferon gamma antagonist
0,276  0,019  Cystic fibrosis treatment
0,265  0,008  Catalase inhibitor
0,325  0,069  Apoptosis antagonist
0,308  0,054  Sensitization
0,278  0,024  Urolithiasis treatment
0,263  0,010  UGT2B10 substrate
0,254  0,003  Antidote, mercury
0,257  0,008  Histidine decarboxylase inhibitor
0,283  0,035  RNA-directed DNA polymerase inhibitor
0,270  0,023  Muscular dystrophy treatment
0,253  0,007  Antirickettsial
0,308  0,064  Radioprotector
0,271  0,027  Antiseptic
0,258  0,015  Aldose reductase substrate
0,264  0,022  CNS active muscle relaxant
0,271  0,032  Pneumotoxic
0,265  0,027  Insulin sensitizer
0,265  0,028  Acaricide
0,243  0,007  GABA C receptor antagonist
0,252  0,016  Uterine stimulant
0,366  0,133  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,242  0,010  Choleretic
0,302  0,069  5 Hydroxytryptamine release stimulant
0,308  0,076  Immunostimulant
0,234  0,004  GST T1-1 substrate
0,233  0,004  GABA aminotransferase inhibitor
0,245  0,017  Cell wall synthesis inhibitor
0,256  0,029  Antiacne
0,235  0,010  Arachidonic acid antagonist
0,231  0,007  ABCA1 expression enhancer
0,242  0,017  SULT1A3 substrate
0,256  0,035  Neurotrophic factor enhancer
0,234  0,012  SULT1A1 substrate
0,235  0,015  Carcinogenic, group 2B
0,242  0,022  Antidiabetic (type 1)
0,245  0,026  Phospholipase C inhibitor
0,233  0,018  Cystathionine beta-synthase inhibitor
0,218  0,008  Adenylate cyclase stimulant
0,223  0,015  Raynaud's phenomenon treatment
0,218  0,011  Antineoplastic, alkylator
0,210  0,004  Glycine receptor agonist
0,249  0,043  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,213  0,008  Folate antagonist
0,236  0,031  Anesthetic
0,213  0,009  NADH dehydrogenase inhibitor
0,221  0,017  Aminopeptidase B inhibitor
0,295  0,092  Vasodilator, coronary
0,246  0,045  Non-steroidal antiinflammatory agent
0,251  0,051  Nitric oxide antagonist
0,216  0,018  Antismoking
0,221  0,025  Antiprotozoal (Coccidial)
0,248  0,052  Peptidyltransferase inhibitor
0,290  0,095  ICAM1 expression inhibitor
0,233  0,038  Thrombolytic
0,223  0,030  Aldehyde oxidase substrate
0,211  0,018  Antieczematic
0,222  0,030  Bone formation stimulant
0,225  0,034  UGT2B15 substrate
0,222  0,031  Antiviral (Hepatitis C)
0,231  0,040  Antiviral (Hepatitis)
0,195  0,004  Ca2+-transporting ATPase inhibitor
0,194  0,003  Antiviral (Parainfluenza)
0,194  0,004  Antifungal (Pneumocystis)
0,269  0,081  CYP2C19 substrate
0,198  0,011  Creatine kinase inhibitor
0,206  0,019  Antiviral (Poxvirus)
0,240  0,054  Chemopreventive
0,218  0,033  Acute respiratory distress syndrome (ARDS) treatment
0,197  0,012  HIV-1 integrase (Overall Integration) inhibitor
0,212  0,028  Antifungal enhancer
0,189  0,006  Acyl-CoA dehydrogenase inhibitor
0,198  0,016  Coagulant
0,235  0,054  Antiviral (West Nile virus)
0,188  0,008  Aminopeptidase I inhibitor
0,189  0,010  GABA C receptor rho-1 antagonist
0,215  0,036  Lipid peroxidase inhibitor
0,197  0,019  UDP-glucose 4-epimerase inhibitor
0,240  0,063  Antihypotensive
0,191  0,015  Mucolytic
0,191  0,015  Photosensitizer
0,179  0,003  Squalene synthetase inhibitor
0,189  0,015  Aldehyde dehydrogenase substrate
0,192  0,020  Antischistosomal
0,208  0,038  Melanin inhibitor
0,180  0,010  DOPA decarboxylase inhibitor
0,224  0,055  Nitric-oxide synthase stimulant
0,205  0,036  Carcinogenic, group 3
0,247  0,078  Antipyretic
0,192  0,024  Antibacterial (Helicobacter pylori)
0,179  0,011  Electrolyte absorption antagonist
0,180  0,013  Prolactin inhibitor
0,208  0,041  Hair growth stimulant
0,172  0,008  UGT2B11 substrate
0,167  0,003  Glutamate (mGluR6) antagonist
0,199  0,036  Genotoxic
0,183  0,020  Alcohol dehydrogenase substrate
0,176  0,014  Actinic keratosis treatment
0,213  0,051  Histone acetyltransferase inhibitor
0,255  0,094  Cardioprotectant
0,180  0,019  NAT2 substrate
0,227  0,067  Psychostimulant
0,201  0,041  Protein kinase stimulant
0,193  0,033  GABA C receptor rho-2 antagonist
0,183  0,024  Expectorant
0,162  0,004  GABA B receptor agonist
0,168  0,012  Keratolytic
0,172  0,017  Arylamine N-Acetyltransferase substrate
0,157  0,002  Arginase inhibitor
0,163  0,012  Anabolic
0,181  0,030  Cell adhesion inhibitor
0,160  0,010  NAT1 substrate
0,176  0,028  Sphingosine 1-phosphate receptor 5 antagonist
0,192  0,044  Phobic disorders treatment
0,153  0,005  Anticholelithogenic
0,189  0,042  Neurotensin receptor agonist
0,155  0,010  Aldose reductase inhibitor
0,169  0,024  Vanilloid 1 agonist
0,154  0,009  Ornithine carbamoyltransferase inhibitor
0,178  0,035  Toll-Like receptor 2 antagonist
0,149  0,008  NMDA receptor agonist
0,187  0,046  Antidote
0,176  0,035  Aldehyde dehydrogenase inhibitor
0,165  0,025  Sphingosine 1-phosphate receptor 2 antagonist
0,150  0,010  Tourette's syndrome treatment
0,163  0,023  Antihelmintic (Fasciola)
0,164  0,025  Contraceptive female
0,212  0,074  Cytotoxic
0,154  0,019  Alcohol dehydrogenase inhibitor
0,143  0,009  Glycine receptor antagonist
0,170  0,036  Antifungal (Cryptococcus)
0,156  0,025  Antiviral (Influenza B)
0,179  0,048  Corneal wound healing stimulator
0,201  0,072  Sedative
0,194  0,065  VEGF expression inhibitor
0,237  0,111  CYP1A2 substrate
0,165  0,039  Retinoprotector
0,152  0,027  Sulfotransferase substrate
0,153  0,028  HDL-cholesterol increasing
0,129  0,004  Free fatty acid receptor 1 agonist
0,128  0,004  SULT2A1 substrate
0,184  0,062  Liver fibrosis treatment
0,126  0,005  Phosphoglycerate kinase inhibitor
0,162  0,043  DNA polymerase I inhibitor
0,155  0,036  Heat shock protein 70 antagonist
0,123  0,005  Antidote, organophosphates
0,154  0,036  Microtubule formation inhibitor
0,135  0,018  Lanosterol 14 alpha demethylase inhibitor
0,129  0,013  Prostaglandin EP2 antagonist
0,126  0,010  Purinergic P2X1 antagonist
0,169  0,053  Skeletal muscle relaxant
0,166  0,052  Mannose-6-phosphate isomerase inhibitor
0,204  0,091  Cyclic AMP phosphodiesterase inhibitor
0,156  0,044  Cyclooxygenase 3 inhibitor
0,131  0,020  Cell adhesion molecule inhibitor
0,130  0,019  Ornithine decarboxylase inhibitor
0,147  0,036  Shock treatment
0,164  0,054  CF transmembrane conductance regulator agonist
0,127  0,018  Glutamate release inhibitor
0,142  0,034  Caspase 3 inhibitor
0,111  0,003  Membrane dipeptidase inhibitor
0,142  0,034  Anticataract
0,110  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,117  0,010  Caspase 9 inhibitor
0,121  0,015  Hyperparathyroidism treatment
0,119  0,014  Prostaglandin antagonist
0,166  0,062  Hexokinase inhibitor
0,185  0,081  CYP2B6 inhibitor
0,119  0,018  Interferon agonist
0,146  0,044  Growth stimulant
0,104  0,003  Glutamate (mGluR8) agonist
0,147  0,047  Adenylate cyclase inhibitor
0,192  0,093  Antialcoholic
0,134  0,036  Carbonic anhydrase III inhibitor
0,110  0,012  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,102  0,005  Anesthetic inhalation
0,113  0,019  Sphingosine 1-phosphate receptor 4 agonist
0,136  0,042  TRPA1 agonist
0,170  0,076  Muscle relaxant
0,109  0,016  GP IIb/IIIa receptor antagonist
0,233  0,140  Antileukemic
0,120  0,027  Antibiotic
0,124  0,032  Interleukin 1 beta converting enzyme inhibitor
0,159  0,068  Antianorexic
0,232  0,141  Transcription factor NF kappa B inhibitor
0,100  0,009  Nitric oxide donor
0,104  0,013  Antitreponemal
0,112  0,022  Granulocyte macrophage colony stimulating factor agonist
0,104  0,015  NMDA receptor glycine site agonist
0,119  0,031  Paget's disease treatment
0,091  0,003  Kainate receptor agonist
0,215  0,129  CYP2D6 substrate
0,105  0,019  Estrogen-related receptor beta agonist
0,095  0,009  Sphingosine 1-phosphate receptor 5 agonist
0,114  0,029  Restless leg syndrome treatment
0,105  0,020  Narcotic antagonist
0,157  0,072  Protein-tyrosine phosphatase inhibitor
0,146  0,061  Pregnane X receptor agonist
0,092  0,008  Alpha-mannosidase inhibitor
0,136  0,053  Gastritis treatment
0,104  0,020  Leukotriene antagonist
0,118  0,035  Carcinogenic, group 2A
0,089  0,006  Retinoid X receptor agonist
0,160  0,077  Antihelmintic (Nematodes)
0,092  0,010  MDM2 inhibitor
0,099  0,017  Maillard reaction inhibitor
0,099  0,017  Integrin antagonist
0,099  0,017  Vanilloid 4 agonist
0,095  0,014  Glutamate (mGluR7) antagonist
0,163  0,081  ATPase inhibitor
0,116  0,035  Glutamate (mGluR7) agonist
0,106  0,026  Na+ K+ transporting ATPase inhibitor
0,086  0,008  Mannosidase inhibitor
0,120  0,043  Gastric antisecretory
0,094  0,019  Peroxisome proliferator-activated receptor gamma antagonist
0,094  0,019  Phospholipase D inhibitor
0,079  0,004  HMG CoA reductase inhibitor
0,091  0,015  Prostaglandin F2 alpha antagonist
0,128  0,054  Menstruation disorders treatment
0,109  0,035  Phosphodiesterase I inhibitor
0,078  0,005  GABA uptake inhibitor
0,108  0,035  Bile acid receptor antagonist
0,090  0,017  Interferon inducer
0,133  0,060  Cathepsin H inhibitor
0,093  0,021  Carbonic anhydrase stimulant
0,091  0,019  Antidote, heavy metal
0,163  0,092  DNA methyltransferase I inhibitor
0,110  0,040  Androgen antagonist
0,128  0,058  Protein-tyrosine phosphatase 1B inhibitor
0,104  0,034  Glutathione S-transferase inhibitor
0,077  0,008  AICAR transformylase inhibitor
0,077  0,008  Pregnane X receptor antagonist
0,078  0,010  Lysophosphatidic acid 3 receptor antagonist
0,084  0,016  Peroxisome proliferator-activated receptor alpha agonist
0,080  0,012  Thromboxane synthase inhibitor
0,178  0,112  5 Hydroxytryptamine 3E antagonist
0,079  0,014  Diacylglycerol O-acyltransferase inhibitor
0,083  0,018  Hypercalcemia treatment
0,126  0,062  Sphingosine 1-phosphate receptor 4 antagonist
0,101  0,037  Carbonic anhydrase XIII inhibitor
0,113  0,049  Chronic obstructive bronchitis treatment
0,072  0,009  Retinoid X alpha receptor agonist
0,069  0,006  Glutamate (mGluR3) antagonist
0,111  0,049  Factor V inhibitor
0,125  0,063  Alkylator
0,190  0,128  Spasmolytic
0,073  0,011  Leukotriene C antagonist
0,096  0,035  Cathepsin G inhibitor
0,074  0,014  CD45 antagonist
0,110  0,051  Antihypermotility
0,072  0,016  DNA helicase inhibitor
0,061  0,005  Prostaglandin D2 agonist
0,162  0,107  DNA methylase inhibitor
0,064  0,009  Dihydrofolate reductase inhibitor
0,078  0,024  Antimycoplasmal
0,073  0,018  Leukotriene B4 antagonist
0,104  0,049  Uric acid excretion stimulant
0,059  0,005  Glutamate (mGluR8) antagonist
0,064  0,010  Peroxisome proliferator-activated receptor delta agonist
0,058  0,004  Glutamate (mGluR3) agonist
0,070  0,017  Ryanodine receptor antagonist
0,078  0,025  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,096  0,043  Contraceptive male
0,092  0,040  D-Ala-D-Ala ligase inhibitor
0,062  0,010  Parathyroid hormone antagonist
0,057  0,005  GABA transporter 3 inhibitor
0,056  0,005  Glutamate (mGluR1a) agonist
0,055  0,004  Prostaglandin F2 alpha agonist
0,058  0,006  Lysine carboxypeptidase inhibitor
0,117  0,066  Antiprotozoal (Babesia)
0,057  0,006  Vitronectin receptor antagonist
0,061  0,010  Guanylate cyclase inhibitor
0,141  0,091  Movement disorders treatment
0,063  0,013  Glutamate (mGluR4) antagonist
0,057  0,006  Free fatty acid receptor 1 antagonist
0,064  0,014  Thymidylate synthase inhibitor
0,058  0,009  Prostaglandin agonist
0,145  0,095  Prostate disorders treatment
0,093  0,044  Hematopoietic
0,057  0,009  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,122  0,074  Antiviral (Papilloma)
0,077  0,029  Exportin-1 inhibitor
0,060  0,013  Glutamate (mGluR group III) antagonist
0,057  0,010  p53 inhibitor
0,052  0,006  Integrin alpha1beta1 antagonist
0,055  0,009  Retinoid X receptor antagonist
0,063  0,018  Carbonic anhydrase IV inhibitor
0,074  0,029  Andropause treatment
0,106  0,062  Gout treatment
0,063  0,019  Adenosine deaminase inhibitor
0,047  0,003  Carbonic anhydrase X inhibitor
0,047  0,003  Carbonic anhydrase VIII inhibitor
0,048  0,005  Excitatory amino acid transporter 2 inhibitor
0,127  0,084  Antineoplastic (squamous cell carcinoma)
0,113  0,071  Interleukin 8 antagonist
0,066  0,024  Thromboxane A2 antagonist
0,068  0,027  Thromboxane antagonist
0,089  0,047  Carbonic anhydrase VI inhibitor
0,110  0,069  Myasthenia Gravis treatment
0,051  0,011  Integrin alpha2 antagonist
0,048  0,007  Prostaglandin D2 antagonist
0,047  0,006  Prostaglandin EP2 agonist
0,056  0,016  Urate transporter 1 inhibitor
0,082  0,041  MAP kinase kinase 7 inhibitor
0,050  0,010  Leukotriene C4 antagonist
0,059  0,020  Toll-Like receptor 2 agonist
0,078  0,040  HIV-1 integrase inhibitor
0,049  0,011  Cholesterol absorption inhibitor
0,047  0,009  Retinoid X alpha receptor antagonist
0,149  0,111  Antihelmintic
0,077  0,039  Leukotriene synthesis inhibitor
0,072  0,035  Protease 3C (Human rhinovirus) inhibitor
0,042  0,005  Prostaglandin EP4 agonist
0,150  0,114  Toxic, respiratory center
0,068  0,032  Androgen agonist
0,051  0,015  Kainate receptor 2 antagonist
0,052  0,016  Dopamine D5 agonist
0,064  0,028  Postcoital contraceptive
0,045  0,011  Leukotriene D4 antagonist
0,048  0,014  Prostacyclin antagonist
0,129  0,095  Diuretic
0,119  0,085  Antihelmintic (Trematoda)
0,063  0,030  Lipocortins synthesis agonist
0,038  0,005  Integrin alphaVbeta1 antagonist
0,036  0,003  Glutamate (mGluR6) agonist
0,042  0,009  Kynurenine 3 monooxygenase inhibitor
0,038  0,005  GRP78 expression inhibitor
0,037  0,005  Prostacyclin agonist
0,039  0,006  Prostaglandin H2 antagonist
0,040  0,009  Peroxisome proliferator-activated receptor alpha antagonist
0,124  0,094  Farnesoid X receptor antagonist
0,166  0,136  Antiviral (Ebola)
0,060  0,030  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,037  0,006  Glutamate (mGluR1) agonist
0,044  0,014  Caspase 2 inhibitor
0,053  0,023  Adenylate cyclase 1 inhibitor
0,047  0,017  AMPA 4 receptor antagonist
0,042  0,012  Tryptophan 5 hydroxylase inhibitor
0,064  0,034  Ribonucleotide reductase inhibitor
0,037  0,007  Lysophosphatidic acid receptor 1 agonist
0,062  0,033  Ribonucleoside-diphosphate reductase inhibitor
0,041  0,012  Lysophosphatidic acid 2 receptor antagonist
0,040  0,011  Leukotriene B4 receptor 1 antagonist
0,099  0,071  Toll-Like receptor 4 antagonist
0,056  0,028  Antimetabolite
0,046  0,018  Farnesoid X receptor agonist
0,080  0,052  Metalloproteinase-2 inhibitor
0,044  0,016  VCAM-1 antagonist
0,034  0,006  Integrin alphaVbeta3 antagonist
0,044  0,016  VCAM antagonist
0,047  0,020  Integrin alpha5beta1 antagonist
0,035  0,008  Nicotinic acid receptor 2 antagonist
0,050  0,023  Geranyltranstransferase inhibitor
0,031  0,003  Thromboxane A2 agonist
0,031  0,005  G-protein-coupled receptor 120 agonist
0,048  0,022  Sphingosine 1-phosphate receptor 1 agonist
0,122  0,096  Pancreatic disorders treatment
0,047  0,022  Nerve growth factor antagonist
0,030  0,004  Retinoid X beta receptor antagonist
0,093  0,067  Interleukin 12 antagonist
0,038  0,013  Hypoxanthine phosphoribosyltransferase inhibitor
0,034  0,009  Prostaglandin E2 agonist
0,237  0,212  Antiarthritic
0,030  0,005  Excitatory amino acid transporter 3 inhibitor
0,038  0,013  Uridine phosphorylase inhibitor
0,056  0,031  Heparanase inhibitor
0,032  0,008  Vanilloid 2 agonist
0,029  0,004  Vesicular glutamate transport inhibitor
0,074  0,050  S-adenosyl-L-methionine decarboxylase inhibitor
0,114  0,090  Contraceptive
0,096  0,072  Carbonic anhydrase XV inhibitor
0,038  0,014  Carboxypeptidase B inhibitor
0,090  0,067  Antiviral (Rhinovirus)
0,028  0,005  Neuraminidase (Influenza B) inhibitor
0,080  0,057  Acetylcholine nicotinic agonist
0,047  0,025  Glutamate (mGluR group III) agonist
0,032  0,010  Retinoid X gamma receptor antagonist
0,050  0,029  Aldosterone antagonist
0,051  0,030  Antiviral (Herpesvirus 3, Human)
0,076  0,055  NAD(P)H dehydrogenase (quinone) inhibitor
0,036  0,014  GABA transporter 2 inhibitor
0,025  0,004  Methylmalonyl-CoA mutase inhibitor
0,044  0,023  Dihydropteroate synthase inhibitor
0,031  0,010  Retinoid X gamma receptor agonist
0,112  0,091  DNA repair enzyme inhibitor
0,025  0,004  Telomerase stimulant
0,083  0,063  Transcription factor NF kappa B stimulant
0,036  0,016  Prostaglandin EP3 antagonist
0,031  0,011  Neutral endopeptidase inhibitor
0,047  0,028  Sphingosine 1-phosphate receptor agonist
0,050  0,030  Cytokine production stimulant
0,056  0,036  Dihydroorotate oxidase inhibitor
0,062  0,043  NMDA 2C receptor antagonist
0,027  0,008  GABA transporter inhibitor
0,028  0,009  Retinoid X beta receptor agonist
0,045  0,026  GABA B receptor antagonist
0,043  0,026  Liver X receptor alpha agonist
0,050  0,032  HCV NS3/NS4A protease inhibitor
0,030  0,012  Thyroid hormone agonist
0,092  0,075  Antifungal (Candida)
0,040  0,023  Vanilloid 3 antagonist
0,027  0,010  Integrin beta5 antagonist
0,050  0,033  Plasminogen activator inhibitor antagonist
0,095  0,079  Antiprotozoal (Toxoplasma)
0,019  0,003  Folate transporter 1 inhibitor
0,031  0,015  Purinergic P2Y15 antagonist
0,020  0,004  Integrin beta6 antagonist
0,040  0,024  5-Alpha-reductase inhibitor
0,037  0,021  Calcitonin receptor agonist
0,029  0,014  Integrin alpha2beta1 antagonist
0,114  0,098  Antihemorrhagic
0,036  0,021  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,043  0,028  Angiotensin AT1 receptor antagonist
0,022  0,007  Excitatory amino acid transporter 1 inhibitor
0,042  0,027  Kainate receptor antagonist
0,029  0,014  Hedgehog signaling activator
0,020  0,005  Lysophosphatidic acid receptor 3 agonist
0,021  0,006  Vitamin D receptor agonist
0,023  0,009  Caspase 8 inhibitor
0,023  0,009  Aminopeptidase A inhibitor
0,042  0,027  Thymidine kinase inhibitor
0,018  0,004  Thromboxane agonist
0,035  0,021  Glutamate (mGluR4) agonist
0,221  0,207  CYP2C19 inhibitor
0,178  0,165  Neuropeptide Y2 antagonist
0,073  0,061  Macrophage migration inhibitory factor inhibitor
0,017  0,005  Carbonic anhydrase XI inhibitor
0,088  0,075  Sphingomyelinase inhibitor
0,029  0,017  VLA-4 antagonist
0,021  0,010  Antibiotic Anthracycline-like
0,024  0,013  Isoleucine-tRNA ligase inhibitor
0,108  0,097  Allergic rhinitis treatment
0,029  0,018  LFA antagonist
0,019  0,008  N-Acetylated alpha-linked acidic dipeptidase inhibitor
0,137  0,127  Hearing loss treatment
0,092  0,082  AMP-activated protein kinase stimulant
0,038  0,029  Retinoic acid alpha receptor agonist
0,054  0,044  Adenine nucleotide translocase inhibitor
0,019  0,010  Potassium channel (Inward rectifier) 11 blocker
0,037  0,027  G protein-coupled receptor agonist
0,017  0,008  GABA transporter 1 inhibitor
0,047  0,038  Dopamine beta hydroxylase inhibitor
0,022  0,013  Lysophosphatidic acid 1 receptor antagonist
0,042  0,033  Heme oxygenase inhibitor
0,078  0,070  Antiviral (Dengue virus)
0,036  0,028  Cholecystokinin B agonist
0,021  0,013  Integrin beta3 antagonist
0,028  0,020  Liver X receptor beta antagonist
0,021  0,012  Antibiotic Quinolone-like
0,070  0,062  SULT1A2 substrate
0,103  0,095  Mental retardation treatment
0,095  0,088  Anesthetic local
0,040  0,033  Macrophage elastase inhibitor
0,022  0,015  Vitamin D receptor antagonist
0,025  0,018  Integrin alpha4 antagonist
0,088  0,081  Phosphodiesterase 6D inhibitor
0,046  0,039  Bombesin 2 receptor antagonist
0,026  0,019  Calcium-sensing receptor agonist
0,086  0,079  Xanthine oxidase inhibitor
0,021  0,015  Kainate receptor 1 antagonist
0,081  0,075  Tocolytic
0,053  0,047  Sphingosine 1-phosphate receptor 1 antagonist
0,038  0,032  Glucagon-like peptide 1 receptor antagonist
0,042  0,036  Glycine transporter 2 inhibitor
0,009  0,004  Integrin alpha5beta6 antagonist
0,025  0,019  Prostaglandin EP4 antagonist
0,046  0,041  Topoisomerase II beta inhibitor
0,021  0,016  Leukotriene B4 receptor 2 antagonist
0,029  0,024  Caspase 6 inhibitor
0,040  0,035  NMDA receptor subunit 3B antagonist
0,027  0,023  Estrogen-related receptor gamma antagonist
0,016  0,012  Thyroid hormone alpha agonist
0,034  0,030  NMDA receptor subunit 3A antagonist
0,019  0,014  5-Alpha-reductase 2 inhibitor
0,039  0,035  Hypogonadism treatment
0,028  0,024  Peptide deformylase inhibitor
0,015  0,011  Purinergic P2Y1 agonist
0,014  0,010  Integrin alphaVbeta6 antagonist
0,010  0,007  Excitatory amino acid transporter 4 inhibitor
0,017  0,014  Nicotinic acid receptor 1 antagonist
0,032  0,029  Angiotensin II receptor antagonist
0,025  0,023  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,057  0,055  Neutrophil collagenase inhibitor
0,007  0,005  Phosphoribosylglycinamide formyltransferase inhibitor
0,053  0,051  Collagenase 3 inhibitor
0,028  0,026  Epoxide hydrolase 1 inhibitor
0,016  0,013  Ileal bile acid transport inhibitor
0,014  0,012  Thyroid hormone alpha antagonist
0,128  0,126  Antipruritic
0,119  0,117  Hemostatic
0,110  0,108  Cachexia treatment
0,012  0,011  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,022  0,020  Fructose-1,6-bisphosphatase 1 inhibitor
0,031  0,029  Carnitine palmitoyltransferase inhibitor
0,156  0,155  Myocardial infarction treatment
0,036  0,036  Oxytocin agonist

